Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2648-2658

  Marathe, Sudhir ^a   Kuriakose, George ^a   Williams, Kevin Jon ^b   Tabas, Ira ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Collagen; Extracellular matrix; Lipoproteins; Sphingomyelinase

Indexed keywords

SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032725610     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2648     Document Type: Article

References (57)

1. Spence MW. Sphingomyelinases. Adv Lipid Res. 1993;26:3-23.
2. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855-1859.
3. Spiegel S, Foster DA, Kolesnick RN. Signal transduction through lipid second messengers. Curr Opin Cell Biol. 1996;8:159-167.
4. Ballou LR, Laulederkind SJ, Rosloniec EF, Raghow R. Ceramide signalling and the immune response. Biochim Biophys Acta. 1996;1301:273-287.
5. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551-561.
6. Williams KJ, Tabas I. The response-to-retention hypothesis of atherogenesis, reinforced. Curr Opin Lipidol. 1998;9:471-474.
7. Xu X, Tabas I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J Biol Chem. 1991;266:24849-24858.
8. Tabas I, Li Y, Brocia RW, Wu SW, Swenson TL, Williams KJ. Lipoprotein lipase and Sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix: a possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J Biol Chem. 1993;268:20419-20432.
9. Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein: proposed role for arterial-wall Sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest. 1996;98:1455-1464.
10. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid Sphingomyelinase gene. J Biol Chem. 1996;271:18431-18436.
11. Schissel SL, Jiang XC, Tweedie-Hardman J, Jeong T, Camejo EH, Najib J, Rapp JH, Williams KJ, Tabas I. Secretory Sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem. 1998;273:2738-2746.
12. Marathe S, Schissel SL, Yellin MJ, Beatini N, Mintzer R, Williams KJ, Tabas I. Human vascular endothelial cells are a rich and regulatable source of secretory Sphingomyelinase: implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem. 1998;273:4081-4088.
13. 2 only aggregation, of low density lipoprotein particles: two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem. 1998;273:29127-29134.
14. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci U S A. 1998;95:3638-3643.
15. Liu B, Hassler DF, Smith GK, Weaver K, Hannun YA. Purification and characterization of a membrane bound neutral pH optimum magnesiumdependent and phosphatidylserine-stimulated Sphingomyelinase from rat brain. J Biol Chem. 1999;273:34472-34479.
16. Schuchman EH, Levran O, Pereira LV, Desnick RJ. Structural organization and complete nucleotide sequence of the gene encoding human acid Sphingomyelinase (SMPD1). Genomics. 1992;12:197-205.
17. Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Desnick RJ. Human acid Sphingomyelinase: isolation, nucleotide sequence, and expression of the full-length and alternatively spliced cDNAs. J Biol Chem. 1991;266:8531-8539.
18. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I. The cellular trafficking and zinc dependence of secretory and lysosomal Sphingomyelinase, two products of the acid Sphingomyelinase gene. J Biol Chem. 1998;273:18250-18259.
19. Fournier N, Paul JL, Alger V, Cogny A, Soni T, de la Llera-Moya M, Rothblat G, Moatti N. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from FuSAH cells to human serum. Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.
20. Jian B, de la Llera-Moya M, Royer L, Rothblat G, Francone O, Swaney JB. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J Lipid Res. 1997;38:734-744.
21. Zhao Y, Sparks DL, Marcel YL. Effect of the apolipoprotein A-I and surface lipid composition of reconstituted discoidal HDL on cholesterol efflux from cultured fibroblasts. Biochemistry. 1996;35:16510-16518.
22. Slotte JP, Bierman EL. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem J. 1988;250:653-658.
23. Skiba PJ, Zha X, Schissel SL, Maxfield FR, Tabas I. The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energydependent. J Biol Chem. 1996;271:13392-13400.
24. Haimovitz-Friedman A, Cordon-Cardod C, Bayoumyb S, Garzotto M, McLoughlin M, Gallily R, Edwards CK III, Schuchman EH, Fuks Z, Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med. 1997;186:1831-1841.
25. Auge N, Andrieu A, Negre-Salvayre A, Thiers JC, Levade T, Salvayre R. The sphingomyelin-ceramide signalling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem. 1996;271:19251-19255.
26. Hashizume T, Kageura T, Sato T. Different effects of cell-permeable ceramide analogs on platelet activation. Biochem Mol Biol Int. 1998;44:489-496.
27. Hoff HF, Morton RE. Lipoproteins containing apo B extracted from human aortas: structure and function. Ann N Y Acad Sci. 1985;454:183-194.
28. Nievelstein PFEM, Fogelman AM, Mottino G, Frank JS. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. Arterioscler Thromb. 1991;11:1795-1805.
29. Guyton JR, Klemp KF. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol. 1996;16:4-11.
30. Jcong TS, Schissel SL, Tabas I, Pownall HJ, Tall AR, Jiang XC. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest. 1998;101:905-912.
31. Schaffner T, Taylor K, Bartucci E, Fischer-Dzoga K, Beeson JH, Glagov S, Wissler RW. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol. 1980;100:57-73.
32. Gerrity RG. The role of the monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1991;103:181-190.
33. Faggioto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate, I: changes that lead to fatty streak formation. Arteriosclerosis. 1984;4:323-340.
34. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colonystimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A. 1995;92:8264-8268.
35. Gu L.OkadaY, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275-281.
36. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894-897.
37. Libby P, Clinton SK. The role of macrophages in atherogenesis. Curr Opin Lipidol. 1993;4:355-363.
38. Ball RY, Stowers EC, Burton JH, Cary NR, Skepper JN, Mitchinson MJ. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 1995;114:45-54.
39. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.
40. Roma P, Catapano AL, Bertulli SM, Varesi L, Fumagalli R, Bernini F. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages. Biochem Biophys Res Commun. 1990;171:123-131.
41. Ryu BH, Mao FW, Lou P, Gutman RL, Greenspan P. Cholesteryl ester accumulation in macrophages treated with oxidized low density lipoprotein. Biosci Biotech Biochem. 1995;59:1619-1622.
42. Klinkner AM, Waites CR, Kerns WD, Bugelski PJ. Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy. J Histochem Cytochem. 1995;43:1071-1078.
43. Musanti R, Ghiselli G. Interaction of oxidized HDLs with J774-A1 macrophages causes intracellular accumulation of unesterified cholesterol. Arterioscler Thromb. 1993;13:1334-1345.
44. Hendriks WL, van der Sman-de Beer F, van Vlijmen BJ, van Vark LC, Hofker MH, Havekes LM. Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase. Arterioscler Thromb Vasc Biol. 1997;17:498-504.
45. Hoff HF, O'Neil J, Pepin JM, Cole TB. Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions. Eur Heart J. 1990;11:105-115.
46. Khoo JC, Miller E, McLoughIin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988;8:348-358.
47. Suits AG, Chait A, Aviram M, Heinecke JW. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci U S A. 1989;86:2713-2717.
48. 4g. Hoff HF, O'Neil J, Chisolm GM III, Cole TB, Quehenberger O, Esterbauer H, Jurgens G. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis. 1989;9:538-549.
49. Sripada PK, Maulik PR, Hamilton JA, Shipley GG. Partial synthesis and properties of a series of N-acylsphingomyelins. J Lipid Res. 1987;28:710-718.
50. Ahmad TY, Sparrow JT, Morrisett JD. Fluorine-, pyrene- and nitroxide-labeled sphingomyelin: semisynthesis and thermotropic properties. J Lipid Res. 1985;26:1160-1165.
51. Havel RJ, Eder H, Bragdon J. The distribution and chemical composition of ultracentrifugally reported lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
52. Edwards IJ, Goldberg U, Parks JS, Xu H, Wagner WD. Lipoprotein lipase enhances the interaction of low density lipoproteins with artery-derived extracellular matrix proteoglycans. J Lipid Res. 1993;34:1155-1163.
53. Cornicelli JA, Witte LD, Goodman DS. Inhibition of LDL degradation in cultured human fibroblasts induced by endothelial cell-conditioned medium. Arteriosclerosis. 1983;3:560-567.
54. Horinouchi K, Erlich S, Perl D, Ferlinz K, Bisgaier CL, Sandhoff K, Desnick RJ, Stewart CL, Schuchman EH. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet. 1995;10:288-293.
55. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
56. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E: evaluation of lesional development and progression. Arterioscler Thromb. 1994;14:141-147.
57. Strong JP, Malcom GT, Oalmann MC, Wissler RW. The PDAY Study: natural history, risk factors, and pathobiology: Pathobiological Determinants of Atherosclerosis in Youth. Ann N Y Acad Sci. 1997;811:226-237.